Medical Condition News

RSS

Iclusig gets FDA approval for two rare blood and bone marrow diseases

The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.

15 Dec 2012

Scientific study: Gazpacho intake can reduce hypertension

A regular consumption of gazpacho can contribute to reduce hypertension, according to a scientific study published in the journal Nutrition, Metabolism & Cardiovascular Diseases, by the researcher Alexander Medina-Remón, from the Department of Nutrition and Bromatology of the Faculty of Pharmacy and the Food and Nutrition Torribera Campus of the UB, as its main author.

15 Dec 2012

Significant correlation between vitamin D and excessive daytime sleepiness

A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor.

14 Dec 2012

MDx, Amarantus sign license agreement for LymPro Alzheimer's disease diagnostic blood test

Amarantus BioScience, Inc., a biotechnology company discovering and developing treatments for diseases associated with protein misfolding and apoptosis, today announced that it has licensed the LymPro Alzheimer's Disease Diagnostic Blood Test (LymPro) from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, Inc.

14 Dec 2012

Approximately 10% of 6-8 year olds have sleep-disordered breathing: Study

Approximately ten per cent of 6-8 year olds have sleep-disordered breathing, according to a recent Finnish study. The risk is increased among children with enlarged tonsils, crossbite and convex facial profile.

14 Dec 2012

Cedars-Sinai physician-scientist receives grant to study Charcot-Marie-Tooth disease

A Cedars-Sinai physician-scientist has been awarded a $3 million grant from the California Institute for Regenerative Medicine to study with new stem cell technology Charcot-Marie-Tooth disease, the most common inherited neurological disorder and which damages nerves that control muscles.

14 Dec 2012

Paroxetine could treat vascular complications of diabetes

University of Texas Medical Branch at Galveston researchers have discovered that the commonly used antidepressant drug paroxetine could also become a therapy for the vascular complications of diabetes.

14 Dec 2012

Scientists discover how Yersinia pestis avoids setting off immune system's early infection-alarm

The plague-causing bacteria Yersinia pestis evades detection and establishes a stronghold without setting off the body's early alarms.

14 Dec 2012

FDA grants accelerated approval to ARIAD’s Iclusig for treatment of CML, Ph+ ALL

ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.

14 Dec 2012

FDA approves Novartis Signifor injection for treatment of Cushing's disease

Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor (pasireotide) injection for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.

14 Dec 2012

Researchers question animal models that measure generalized anxiety disorder

Pre-clinical trials - the stage at which medications or therapies are tested on animals like laboratory mice - is a crucial part of drug development. It's only then that scientists can assess benefits and side effects before a drug is administered to patients.

14 Dec 2012

IOF kicks off 3rd Asia-Pacific Osteoporosis Meeting

Doctors and researchers from across the Asia-Pacific gathered today for the opening of the International Osteoporosis Foundation's (IOF) 3rd Asia-Pacific Osteoporosis Meeting, taking place at the Kuala Lumpur Convention Centre until December 16, 2012.

14 Dec 2012

National Cheng Kung University kicks off 23rd International Conference on Genome Informatics

National Cheng Kung University kicked off GIW 2012 -- the 23rd International Conference on Genome Informatics -- at International Conference Hall Dec. 12, attracting more than 140 scholars from 10 countries including Japan, Korea, China, Singapore, Canada, America, Germany, and Australia.

14 Dec 2012

Low-wage workers vulnerable to financial hits that can result from on-the-job injuries and illnesses

Low-wage workers, who make up a large and growing share of the U.S. workforce, are especially vulnerable to financial hits that can result from on-the-job injuries and illnesses, according to a policy brief released today by researchers at the George Washington University School of Public Health and Health Services (SPHHS).

14 Dec 2012

Novel antibodies can aid in early diagnosis of Sjogren's Syndrome

Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics, Inc. The breakthrough, described in a paper in the December issue of Clinical Immunology, will allow patients to be treated sooner when they are much more likely to benefit.

14 Dec 2012

Researchers turn light into heat on the nanoscale to trigger biochemical reactions

Since Edison's first bulb, heat has been a mostly undesirable byproduct of light. Now researchers at Rice University are turning light into heat at the point of need, on the nanoscale, to trigger biochemical reactions remotely on demand.

14 Dec 2012

Survey identifies career burnout as significant problem among hospital-based neurologists

A survey has identified career burnout as a significant problem among neurologists who predominantly work with hospital inpatients.

14 Dec 2012

ETA receptor antagonism reduces novel cardiovascular risk factors in patients with CKD

Blocking the receptor for proteins that constrict blood vessels reduces markers of heart-related problems in patients with chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

14 Dec 2012

States face Friday deadline on health exchanges

States must decide by Dec. 14 if they are going to operate their own health care marketplaces, or if they will defer to the federal government. They have until mid-February to decide whether to partner with the federal government or let the feds do it all. Meanwhile, polls in Missouri and Tennessee show public support for state-run markets.

14 Dec 2012

Biological factors, cell behaviour drive tumour growth contributing to therapy failure and relapse

Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal cancer, they found that genetic mutations, regarded by many as the chief suspect driving cancer growth, are only one piece of the puzzle. The team discovered that biological factors and cell behaviour - not only genes - drive tumour growth, contributing to therapy failure and relapse.

14 Dec 2012

Medical Condition News

Iclusig gets FDA approval for two rare blood and bone marrow diseases

Scientific study: Gazpacho intake can reduce hypertension

Significant correlation between vitamin D and excessive daytime sleepiness

MDx, Amarantus sign license agreement for LymPro Alzheimer's disease diagnostic blood test

Approximately 10% of 6-8 year olds have sleep-disordered breathing: Study

Cedars-Sinai physician-scientist receives grant to study Charcot-Marie-Tooth disease

Paroxetine could treat vascular complications of diabetes

Scientists discover how Yersinia pestis avoids setting off immune system's early infection-alarm

FDA grants accelerated approval to ARIAD’s Iclusig for treatment of CML, Ph+ ALL

FDA approves Novartis Signifor injection for treatment of Cushing's disease

Researchers question animal models that measure generalized anxiety disorder

IOF kicks off 3rd Asia-Pacific Osteoporosis Meeting

National Cheng Kung University kicks off 23rd International Conference on Genome Informatics

Low-wage workers vulnerable to financial hits that can result from on-the-job injuries and illnesses

Novel antibodies can aid in early diagnosis of Sjogren's Syndrome

Researchers turn light into heat on the nanoscale to trigger biochemical reactions

Survey identifies career burnout as significant problem among hospital-based neurologists

ETA receptor antagonism reduces novel cardiovascular risk factors in patients with CKD

States face Friday deadline on health exchanges

Biological factors, cell behaviour drive tumour growth contributing to therapy failure and relapse

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News